Vetter�s Skokie Facility Expansion nears Completion

Facility growth is necessary to help meet customer demands and new product requirements

�

• Demonstration of consistent
  strategy to stay at the forefront in the market
• Expansions will
  help meet an increase in customer projects
• A second
  extension is in the final planning stage

SKOKIE, USA and RAVENSBURG, GERMANY - Media OutReach - April 17, 2019 – Vetter, a global operating Contract Development and Manufacturing
Organization (CDMO) announced today that a significant level of expansion
activities are nearing completion at its US clinical manufacturing facility
located at the Illinois Science & Technology Park in suburban Chicago. The
ongoing growth of the facility will help satisfy existing and ever-increasing
future customer requirements as well enable meet the complex needs of newer
drug molecules like peptides or antibodies, many which need refrigeration or
freezing. New offices with 45 work stations, conference rooms and an archive
room are also included. To support the increase in customer projects, a
permanent second work shift will be added in Visual Inspection over the next
months. A second shift in Quality Oversight is also planned. “This variety of
activities is a further proof point of Vetter’s consistent strategic approach
to stay ahead of the market by focusing on the important service needs of our
customers during their drug development journey;
promptness; flexibility; high yield of their valuable API and, of course high
quality,” explains Dr. Claus Feussner, Senior Vice President of Vetter
Development Service.

 

  

Inside
the new freezer farm at Vetter’s US Development Service site.
Picture
source: Vetter Pharma International GmbH

  

Since beginning full operations in late
2011, Vetter’s US early-stage development site has been expanding to help meet
growing customer demands. As recently as 2016, the site expanded its storage capacity
by 150 percent to 3,700 sq. ft. With the new additions, most of which are expected
to be completed by April, the site will increase its storage space by an
additional 3,100 sq. ft. The new storage includes a 2,500 sq. ft. freezer farm
as well as a planned 600 sq. ft. walk-in refrigerator. In total, 6,800 sq. ft.
of storage space will result. A second extension, now in the final planning
stage, will include an additional 1,500 sq. ft. of room temperature and freezer
space. “When completed, the facility will have more than double the overall storage
space we have currently available. This extensive expansion of freezer and
refrigeration storage space represents the ongoing evolution in our Chicago
business,” summarizes Dr. Susanne Lemaine, Vice President Vetter Development
Service Chicago. 

 

Find
the Vetter press kit and more background information here

About Vetter

Headquartered
in Ravensburg, Germany, Vetter is a global leading contract development and
manufacturing organization (CDMO) with production facilities in Germany and the
United States. Currently
employing 4,500 individuals worldwide, the company has long-term
experience in supporting biotechnology and pharmaceutical customers both large
and small. Vetter services range from early stage development
support including clinical manufacturing, to commercial supply and numerous packaging solutions for vials,
syringes and cartridges. As a leading solution provider, Vetter appreciates its
responsibility to support the needs of its customers by developing devices that
contribute to increased patient safety, convenience, and enhanced compliance.
Great importance is also given to social responsibility including environmental
protection and sustainability. Learn more about Vetter at www.vetter-pharma.com.